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Abstract
Although the mechanism of action of antimicrobial peptides (AMPs) is not clear,
they can interact electrostatically with the cell membranes of microorganisms. New
ocellatin-PT peptides were recently isolated from the skin secretion of Leptodactylus
pustulatus. The secondary structure of these AMPs and their eﬀect on Leishmania
infantum cells, and on diﬀerent lipid surface models was characterized in this work.
The results showed that all ocellatin-PT peptides have an a-helix structure and ﬁve
of them (PT3, PT4, PT6 to PT8) have leishmanicidal activity; PT1 and PT2 aﬀected
the cellular morphology of the parasites and showed greater aﬃnity for leishmania
and bacteria-mimicking lipid membranes than for those of mammals. The results
show selectivity of ocellatin-PTs to the membranes of microorganisms and the
applicability of biophysical methods to clarify the interaction of AMPs with cell
membranes.
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1 | BACKGROUND
Antimicrobial peptides (AMPs) are ubiquitous naturally
occurring molecules forming part of many species’ innate
immune system. They have between 12 and 50 residues and
most of them are cationic-amphipathic molecules often with
a high content of a-helix in their structure.[1] Antibacterial
activity is the most commonly tested antimicrobial activity
for AMPs, however many other activities have also been
described.[2] Regarding antiparasitic activity of AMPs, only
83 of more than 990 active peptides derived from amphib-
ians registered at APD have been tested as antiparasitic,
mostly having been tested for antimalaria activity.[3] Further-
more, no correlation between antibacterial and antiparasitic
activity potencies was observed in those AMPs that have
been tested.[4] Antimicrobial peptides have potential to form
a new class of molecules able to treat neglected diseases,
including those caused by parasites.[5] Although the mecha-
nisms of action of AMPs against parasites are not fully
understood, it has been demonstrated that generally, AMPs
kill target cells by disrupting the cell membranes.[6]
High-resolution microscopy techniques are powerful tools
to observe the eﬀect of antimicrobial agents on the morphol-
ogy of microorganisms with resolutions on the order of a few
nanometers to fractions of nanometers.[7] Both scanning elec-
tron microscopy (SEM) and atomic force microscopy (AFM)
give information about sample surface topography.
AFM allows sample observation under ambient condi-
tions, with no requirement for a conductive coating. More-
over, AFM permits the quantiﬁcation of roughness of
membranes. Compared to AFM, SEM requires more com-
plex sample preparation procedures for biological samples
since it’s a vacuum technique, but is more appropriate for
characterizing large numbers of cells, since the ﬁeld of view
can be wider, and imaging is considerably faster.
The eﬀects of AMPs observed on the surface structure of
microorganisms can be related to their aﬃnities to the lipid
composition of the membrane: prokaryotic and eukaryotic
membranes vary considerably in lipid contents. Anionic lip-
ids are exposed at the surface of many bacterial membranes,
while in eukaryotic membranes contain very low concentra-
tions of anionic lipids. Phosphatidylethanolamine (PE) is
present at high concentration in many bacteria specie surfa-
ces, while in mammalian cells, this lipid makes up less than
5% of the surface lipid composition. Several studies show
the increasing role of PE as a lipid receptor in the action of
AMPs (reviewed in Ref. 8). Phosphatidylglycerol (PG) is
another of the essential components of bacterial cell mem-
branes, which confers a negative charge at physiological pH
and has a role is providing bacterial membrane stability.[9]
Overall, PE and PG make up a great proportion of the lipid
contents of the E. coli inner membrane.[10] In the case of par-
asites, a number of studies demonstrate that phosphatidyl-
choline (PC) and PE are the two most abundant
phospholipid classes in the membrane of some species,
including Leishmania.[11] Surface plasmon resonance (SPR)
is a useful tool for studying membrane aﬃnity of small mole-
cules. This technique can be used to measure the interaction
of peptides with diﬀerent synthetic lipid bilayer models.[12]
In this work, dimyristoylphosphatidylcholine (DMPC) is
used as a model for eukaryotic membranes while POPE:
POPG (75:25) and POPC:POPE (75:25) are used as models
for E. coli and parasite membranes, respectively. These ﬁrst
two have been used by other authors as models for these
classes of cell,[9a,13] while to our knowledge no work on
model membranes of Leishmania has been carried out.
Recently we isolated eight new AMPs from the skin
secretion of Leptodactylus pustulatus. They belong to the
ocellatin peptide family found in the genus Leptodactylus.
The ﬁrst member of this family, ocellatin-1, was described in
the specie Leptodactylus ocellatus,[14] then 23 more peptides
were described with similarities in amino acid sequence in
seven species of the same genus.[14,15] This family of pep-
tides was predicted to have an amphipathic a-helix second-
ary structure and they possess in general low potency against
Gram-negative tested strains and no activity or higher MICs
for Gram-positive strains.
However no biological eﬀects other than bacterial growth
inhibition have been described for ocellatin peptides except
for plasticin-L1 that presented a modest insulin-releasing
eﬀect when tested in vitro[16] and leptoglycin and ocellatin-F
(fallaxin) that were tested against human pathogenic fungi
but did not show any growth inhibition.[17] In this work we
characterized the secondary structure of ocellatin-PT peptides
by circular dichroism (CD) and we evaluated their eﬀect in
vitro in Leishmania infantum (= L. chagasi) cultures, by
high-resolution microscopy techniques (AFM and SEM),
and on diﬀerent lipid systems by SPR.
2 | METHODS
2.1 | Peptide synthesis and characterization
All of the peptides were manually synthesized using a solid-
phase approach using F-moc/tert-butyl chemistry. Peptide
elongation was carried out in polypropylene syringes ﬁtted
with a polyethylene porous disk. Solvents and soluble
reagents were removed by suction. A Wang resin (Peptides
International) was used for the synthesis of the peptides,
except when the amidated N-terminal peptides were pro-
duced, for which a Rink amide MBHA resin (Peptides Inter-
national) was used. Samples were treated with triﬂuoroacetic
acid/triisopropylsilane/water (TFA/TIS/H2O) (95:2.5:2.5) for
removal of the protecting group. Peptide puriﬁcation was
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carried out by preparative RP-HPLC (Phenomenex columns
Kinetex 5 lm C18 50 3 21.20 mm) using a Shimadzu
Prominence instrument. Each peptide was dissolved in H2O/
CH3CN (6:4) and submitted to an RP-HPLC system using a
gradient of CH3CN, starting with H2O/0.1% TFA and rising
to 100% CH3CN over 15 minutes.
[15a] The formula
(A2152A225)3144 (lg/mL) was applied for peptide quantiﬁ-
cation.[18] Purity and molecular mass determination of syn-
thetic peptides were performed using a MALDI-TOF/TOF
(UltraﬂeXtreme, Bruker Daltonics) instrument operated in
the positive ion mode and controlled by the Compass for
Flex software, version 1.3 (FlexControl 3.3, FlexAnalysis
3.3, Bruker Daltonics); 5,000 laser shots were accumulated
per spectrum in the MS and MS/MS modes. One-microliter
aliquots of the chromatographic fractions dissolved in an
a-cyano-4-hydroxycinamic acid matrix solution (1:3, v/v)
were applied on a stainless steel plate and dried at room tem-
perature for 30 minutes. The peptide monoisotopic mass was
obtained in reﬂector mode with external calibration, using
the Peptide Calibration Standard for Mass Spectrometry mix-
ture (up to 4000 Da mass range, Bruker Daltonics). Isolated
peptides were submitted to an automatic sequencer for de
novo sequencing using LIFT mode.[15a] All peptides synthe-
sized and used in this study are shown in Supporting Infor-
mation Table S1. All peptides synthesized as well as some
physico-chemical characteristics relevant as isoelectric
point[19] and GRAVY (Grand Average of Hydropathy)[20]
are shown in Supporting Information Table S1.
All peptides synthesized and used in this study were
obtained at >99% purity by HPLC. The molecular weights were
determined as: Ocellatin-PT1 (Mw 2639.1;
[M1H]1=2638.24 Da), Ocellatin-PT2 (Mw 2609;
[M1H]1=2607.68 Da), Ocellatin-PT3 (Mw 2530;
[M1H]1=2528.53 Da), Ocellatin-PT4 (Mw 2595.1;
[M1H]1=2593.46 Da), Ocellatin-PT5 (Mw 2667.1;
[M1H]1=2666.45 Da), Ocellatin-PT6 (Mw 3364.9;
[M1H]1=3365.74 Da), Ocellatin-PT7 (Mw 3293.8;
[M1H]1=3293.69 Da), Ocellatin-PT8 (Mw 3312.9;
[M1H]1=3312.71 Da). All the mass spectrometry data are
published in the supporting information of the article.[13]
2.2 | Antileishmania assays
Parasite cultures. Leishmania infantum promastigotes
(MHOM MA67ITMAP263) were cultured at 25°C in RPMI
1640 Glutamax (Gibco) supplemented with 10% (v/v) iFBS,
50 U mL21 penicillin, 50 mg/mL streptomycin, and 20 mM
HEPES sodium salt pH 7.4 (Sigma). Axenic amastigotes of
the same strain were grown at 37°C and 5% CO2, in MAA
medium supplemented with 20% (v/v) iFBS, 2 mM Gluta-
max (Gibco), and 0.023 mM hemin (Sigma), as described
previously.[21]
2.3 | Assessment of leishmanicidal activity
For determination of the leishmanicidal activity of the pep-
tides, L. infantum parasites at late exponential phase of
growth were placed in 96-well plates: (i) promastigotes were
seeded at 3 3 105 cells per well in complete RPMI medium,
(ii) axenic amastigotes were seeded at 1.5 3 105 cell per
well in MAA20. Parasites were exposed to diﬀerent concen-
trations of peptides for 24 h. Parasite viability was then
determined by the resazurin assay[22] and calculated as the
percentage in relation to control cultures. Data were analyzed
with GraphPad Prism 5 software and IC50 values
determined.
2.4 | Generation of bone-marrow derived macrophages
(BMDM)
Bone-marrow (BM) cells were isolated by ﬂushing femurs
and tibia of BALB/c mice with Hank’s Balanced Salt Solu-
tion (HBSS, Gibco), and diﬀerentiated into BM derived mac-
rophages (BMDM) via an adaptation of a previously
described protocol.[23] Brieﬂy, BM cells were collected, cen-
trifuged and suspended in Dulbecco’s Modiﬁed Eagle’s
Medium (DMEM) supplemented with 10% inactivated Fetal
Bovine Serum (iFBS), 1% of Minimum Essential Media
non-essential amino acids solution (MEM), 50 U.mL21 peni-
cillin, 50 mg/mL streptomycin (all from Gibco) (complete
DMEM medium or cDMEM), and 10% L929 cell condi-
tioned medium (LCCM) as a source of macrophage-colony
stimulating factor (M-CSF). BM cells were cultured in petri
dishes for 24 h at 37°C in a 7% CO2 atmosphere in order to
remove diﬀerentiated cells. Non adherent cells were then
counted, plated in 96-well plates (2.5-3 3 104 cells per well)
and incubated at 37°C in a 7% CO2 atmosphere. On the 4
th
and 7th day, cDMEM1 10% LCCM medium was renewed.
After 10 days the culture was composed of diﬀerentiated
macrophages.
2.5 | Assessment of cytotoxicity to BMDM
Cytotoxicity of peptides was determined in BMDM using a
standard resazurin assay.[22] Cultures of BMDM were sup-
plemented with diﬀerent concentrations of the test com-
pounds and further incubated for 24 h. Then, 10% (v/v) of a
2.5 mM resazurin solution (Sigma) was added to each well.
Cells were incubated for 2 h and ﬂuorescence measured
(560Ex/590Em) using a SpectraMAX GeminiXS microplate
reader (Molecular Devices LLC). The percentage of viable
BMDM was calculated in relation to control cultures to
which no peptides were added. Data were analyzed with
GraphPad Prism 5 software and 50% cytotoxic concentration
(CC50) values determined.
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2.6 | Circular dichroism studies
We studied the secondary structure content by CD spectros-
copy in the far UV, using a Jasco J-815 CD Spectropolarime-
ter (Jasco Corp.). The measurements were performed under
nitrogen gas ﬂow of 8 L/hour at a temperature of 20°C, con-
trolled by a Peltier system (JASCO). Spectra were recorded
between 190 and 260 nm, using a 10 mm cell path length.
The peptide concentrations were 100 mM and the 2,2,2-Tri-
ﬂuoethanol (TFE) concentrations were 0%, 10%, 20% and
40% (v/v) in Milli-Q water. For the studies using liposomes,
the LUVs (for preparation details see below) were used at a
lipid concentration of 1 mMdm23, and peptides were used at
100 lM concentration. These experiments were carried out
at a controlled temperature of 37°C, and other conditions
were the same as for the TFE studies. In order to reduce the
interference by light scattering from the vesicles, a reference
spectrum of a solution containing only LUVs in buﬀer, with
no peptide was used as a background and subtracted from
the spectra before plotting and before analysis. We used a
scan speed of 50 nm/min, a response time of 1 s and a band-
width of 1 nm. The spectra were converted to molar elliptic-
ity per residue by using the relationship: []/(10 3 c 3
n3d), here [] is the molar ellipticity (in degrees 3 cm2 3
dmol21),  the ellipticity in millidegrees, n is the number of
peptide bonds and c its molar concentration, d the length of
the cell in centimeters. Helicity content estimates were calcu-
lated using the Dichroweb online service,[24] using the
CONTIN-LL method.[25]
2.7 | Morphological studies using SEM and AFM
To evaluate the morphological eﬀects resulting from treat-
ment with ocellatin-PT peptides, we select two of the eight
peptides, to represent both ocellatins size classes used in this
study. Ocellatin-PT1 represents those with small size (25 res-
idues) and ocellatin-PT8 represents large size peptides (31
residues). These peptides were also selected because of their
low cytotoxicity to mammalian cells.
We used a 96 well microculture plate with 100 mL of
RPMI 1640 per well, to which were added 2 3 106 pro-
mastigote forms per well, in triplicate. Three conditions
were studied: a negative control (no peptide), a sample
treated with ocellatin-PT1 or ocellatin-PT8 at the concen-
tration of 16 mg/mL and 64 mg/mL. Plates were incubated
at 37°C for 24 h. Cultures were transferred to tubes and
were centrifuged at 100 3 g for 15 minutes. Culture
medium was removed and a wash with sodium cacodylate
buﬀer was performed (5 minutes, 100 mM; pH 7.2), after
buﬀer removal a primary ﬁxation with glutaraldehyde
solution (60 minutes, 2.5% in 100 mM Na-cacodylate, pH
7.2) was made. After this time, two buﬀer washes were
made to remove glutaraldehyde. The cells were then trans-
ferred to poly-L-lysine-treated glass slides (10 mm diame-
ter) and they were left to settle for 60 minutes. Later, the
samples were washed (twice) with ultrapure water, and
slides were covered with osmium tetroxide solution (at 4°
C, 1% in 100 mM Na-cacodylate buﬀer, pH 7.2) for sec-
ondary ﬁxation. After this, the osmium tetroxide solution
was removed by ultrapure water wash, and then the sam-
ples were treated with a graded ethanol series for dehydra-
tion (25, 50, 75, and 100% twice, 5 minutes each). Finally,
the samples in 100% ethanol were transferred to a critical
point drying (CPD) device. After CPD the samples were
maintained in a dry environment. The samples were then
divided in two. One set of these samples were subjected to
Au/Pd coating before SEM analysis; the other set of sam-
ples was used for AFM analysis without further treatment.
SEM was performed using a FEI Quanta FEG 400
scanning electron microscope. Images were collected in
both secondary electron (SE) and (BSE) imaging modes.
Typical imaging conditions were 15 kV acceleration, and
10-12 mm working distance; spot size and aperture were
adjusted to achieve the best possible resolution. Many
areas were imaged per sample, representative images are
shown.
AFM was performed with a TT-AFM atomic force
microscope from AFMWorkshop. A 50 3 50 3 17 mm
scanner was used, in vibrating mode. ACT probes from
AppNano were used with resonance frequencies of
approximately 300 kHz. Images were processed and dis-
played using Gwyddion software, which was also used to
calculate RMS roughness (Rq) of central areas of mem-
branes of the parasites. A p value of <0.05 was considered
to be signiﬁcant.[7a]
2.8 | Liposome preparation
2.8.1 | Liposome preparation
Lipid ﬁlms were prepared by evaporation of a lipid solution
in chloroform using a stream of argon. The lipids POPE,
POPG, POPC and DMPC were weighed in order to have
ﬁnal stock lipid dispersions (POPE:POPG (75:25); POPC:
POPE (75:25); DMPC) with 2 mmoldm23. The ﬁlms were
left under vacuum for 3 h to remove all traces of the organic
solvent. Resulting dried lipid ﬁlms were dispersed with
HEPES buﬀer (0.1 M NaCl, pH 7.4) then the mixture was
vortexed above the phase transition temperature of the lipid
(40± 0.1°C used for all lipid systems studied) to produce
multilamellar large vesicles (MLVs). The MLVs were proc-
essed by ﬁve cycles of freezing in liquid nitrogen and thaw-
ing by brief immersion in a boiling water bath. Lipid
suspensions were then equilibrated above the phase transition
temperature of the lipid for 30 min and extruded 10 times
through 100 nm polycarbonate ﬁlters to produce large
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unilamellar vesicles (LUVs). Extrusion of the liposomes was
performed using a LIPEX Biomembranes extruder attached
to a thermostatic circulating water bath. The size distribution
of the LUVs was determined by dynamic light scattering
(DLS) analysis using a Malvern Instruments ZetaSizer Nano
ZS and the hydrodynamic diameters are listed in Supporting
Information Table S2.
2.9 | SPR measurements
SPR experiments were carried out using a Biacore X100 ana-
lytical system with a L1 sensor chip (Biacore). Prior to use,
the L1 chip surface was washed with a conditioning cycle
consisting on the injection of 3-[(3-cholamidopropyl)dime-
thylamonio]-1-propanesulfonate (CHAPS), 20 mmol.dm23
followed by running buﬀer (HEPES). The interaction of the
ocellatins-PT1 and PT8 with the lipid models was examined
at peptide concentrations of 0, 2, 3, 4, and 5 lmol.dm23 and
a distinct SPR cycle was performed for each peptide concen-
tration tested. Three types of vesicles were tested: DMPC,
POPC:POPE (75:25), and POPE:POPG (75:25). Each SPR
cycle consisted of vesicle immobilization on the chip surface
with an injection of the 1 mmol.dm23 LUV suspension, at a
ﬂow rate of 2 ll/min for 45 min. This was followed by suc-
cessive injections of running buﬀer (50 ll/min for 100s) and
1 mmol.dm23 NaOH (50 ll/min for 60 s). Stabilization ﬁn-
ished with an injection of running buﬀer at 5 ll/min for
500 s. After stabilization, peptide solution was injected at a
ﬂow rate of 10 ll/min during 100 s followed by a dissocia-
tion time of 10 min (Supporting Information Figure S1).
Then the lipids were removed by a double injections of
CHAPS and running buﬀer, both at a ﬂow rate of 10 ll/min
for 150 seconds. The running buﬀer was 20 mM phosphate
buﬀer pH 7.4, 150 mM NaCl. Kinetic analysis of the sensor-
grams was performed using the two-state curve ﬁtting
model.
3 | RESULTS
3.1 | Biological assays
In this work, we analyzed the biological activity of eight
ocellatin-PT peptides against L. infantum promastigotes and
amastigotes and their cytotoxicity to bone marrow-derived
macrophages (BMDM).
Anti-parasitic activity of PT3, PT4, PT6, PT7, and PT8
eliminated half of the promastigote population (Table 1 and
Supporting Information Figure S2) at concentrations between
9.8 and 15.4 mM, while 50% inhibitory concentrations (IC50)
of ocellatins PT1, PT2 and PT5 were 24, 49 and 26 mM.
Amastigotes were more resistant to the action of these
AMPs, the most eﬀective being Ocellatin-PT6 and PT4 that
showed (IC50 of 19.8 and 28.9 mM, respectively (Table 1
and Supporting Information Figure S3). None of the other
peptides had a detectable eﬀect on the amastigotes in the
concentration range tested.
As depicted in Table 1 and Supporting Information Fig-
ure S4, the cytotoxicity of the AMPs toward our mammalian
cell model, bone marrow-derived macrophages (BMDM),
was in general low. All the peptides presented 50% cytotox-
icity concentrations (CC50) superior to the highest concentra-
tion tested, 150 mM (>512 mg/mL) with the exception of
PT4 that had a CC50 of 101.5 mM.
3.2 | STRUCTURAL STUDIES
Ocellatin-PT secondary structures were studied using CD
spectroscopy both in the absence and presence of increasing
amounts of TFE, and selected peptides were further probed
in the presence of the three membrane models used in this
work, namely DMPC—the mammalian cell membrane
mode), POPE:POPG (75:25)—Gram negative bacterial cell
TABLE 1 Antileishmania activity against Leishmania infantum and cytotoxicity of Ocellatins
Peptides
IC50 (lg/mL/lmol.dm
23)
Promastigotes
IC50 (lg/mL/lmol.dm
23)
Axenic Amastigotes
Cytotoxicity CC50 (lg/mL) bone
marrow-derived macrophages (BMDM)
macrophages
Ocellatin-PT1 63.4/23.9 NADa > 512
Ocellatin-PT2 128/ 49.1 NAD > 512
Ocellatin-PT3 34/13.4 NAD > 512
Ocellatin-PT4 25.6/9.8 75/28.9 263.4
Ocellatin-PT5 62.7/25.5 NAD > 512
Ocellatin-PT6 42.6/12.7 67.5/19.8 > 512
Ocellatin-PT7 42.2/72.8 NAD > 512
Ocellatin-PT8 51.6/15.5 NAD > 512
aNo activity was detected at the highest antibiotic concentration tested.
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membrane model, and POPC:POPE (75:25)—the cell mem-
brane model for leishmania. CD studies were performed in
order to be compared with the three-dimensional structural
models of ocellatin-PT peptides previously described using
the web resource PEP-FOLD[19]. Three-dimensional struc-
ture predictions previously described showed two similar a–
helix structures in all Ocellatin-PT peptides: one smaller at
the N-terminal that covered residues 1 to 8 separated by a
small random coil from a bigger a–helix that covered 11–20
residues. Predicted models showed small diﬀerences prob-
ably due to some residue diﬀerences between peptides[19].
CD measurements of ocellatin-PT peptides in water and 10%
of TFE indicate a random conformation with a minimum
close to 198 nm (Figure 1). However as TFE concentration
increases, the shape of CD spectra suggest the tendency to
form deﬁned secondary structures. All CD spectra at 40%
TFE showed one maximum at 191 nm and two minima
around 207 and 220 nm characteristic of a–helix structures
FIGURE 1 Circular dichroism of peptides in aqueous solution and in 2,2,2-TFE. (A) Ocellatin-PT1, (B) Ocellatin-PT2, (C)
Ocellatin-PT3, (D) Ocellatin-PT4, (E) Ocellatin-PT5, (F) Ocellatin-PT6, (G) Ocellatin-PT7, and (H) Ocellatin-PT8
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FIGURE 2 Circular dichroism of peptides in buﬀer (PBS) and in solutions (all 1mM) of LUVs in the same buﬀer. Left:
Ocellatin-PT1, Right: Ocellatin-PT8
FIGURE 3 Scanning ElectronMicroscopy imaging of L. infantum promastigote forms. (A) Control cell. (B) Cell treated with
16 mg/mL of ocellatin-PT1. (C) Cell treated with 16 mg/mL of ocellatin-PT8. (D) Cell treated with 64 mg/mL of ocellatin-PT1. (E)
Cell treated with 64 mg/mL of ocellatin-PT8. All images are SE images
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(Figure 1). Estimated helical contents were calculated and
the results included in the supporting material (Supporting
Information Table S3). The estimated helicities varied form
peptide to peptide, being as low as ca. 17% for Ocellatin PT-
3, to over 38% for Ocellatin PT-8. However, all peptides
showed increased helicity with increasing TFE concentra-
tion. This data correlates with the results obtained for
plasticin-L1, the only one of the 23 AMPs isolated from the
skin secretion of frogs from the genus Leptodactylus that has
been previously studied by CD[21]. Plasticin-L1 CD spectra
showed a helical structure when dissolved in 50% TFE, but
not when dissolved in water or methanol[21]. This solvent-
dependent structure adoption could indicate that these pep-
tides are unstructured until interaction with microorganism
membranes, as was previously demonstrated for AMPs of
other species.
In order to test this hypothesis, we also tested the CD
response of two selected peptides (ocellatins PT-1 and PT-8)
to the presence of lipid membranes in the form of LUVs.
These two peptides were chosen as representing diﬀerent
properties of the peptides within this class, Ocellatin–PT1
being a shorter peptide with relatively low charge (25 resi-
dues, pI of 8.44) while Ocellatin–PT8 is the longest peptide
in the group and highly cationic (32 residues, pI of 9.82).
They were tested against LUVs made up of DMPC, POPE:
POPG (75:25) and POPC:POPE (75:25). Results are shown
FIGURE 4 Atomic force microscopy images of L. infantum promastigote forms. Control cell: (A) Amplitude image and (B) 3D
representation of height image of the same control cell. A cell treated with 16 mg/mL of Ocellatin-PT1: (C) Amplitude image and
(D) 3D representation of height image of the same treated cell. A cell treated with 16 mg/mL of Ocellatin-PT8: (E) Amplitude image
and (F) 3D representation of height image of the same treated cell
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in Figure 2, and estimated helicity percentages are reported
in Supporting Information Table S4. The results show
environment-dependent structural changes in the peptides,
conﬁrming the results shown with the TFE. The results how-
ever, were somewhat more complex. Overall, while we saw
increases in helicity when the peptides were solutions con-
taining lipid vesicles, the amount of secondary structure
depended strongly on the peptide studied and the type of
lipid in the vesicle. Both peptides studied developed alpha
helical character in the presence of the bacterial membrane-
mimicking model (POPE:POPG), but to a lesser extent, in
the case of leishmania membrane model (POPC:POPE). Fur-
thermore, in the case of the DMPC, the peptide Ocellatin-
PT1 developed considerable helical content, while the Ocel-
latin PT-8 peptide did not. This contrast with cytotoxicity
results reported here (Supporting Information Figure S4),
and previously,[15a] showing no diﬀerence between these
peptides in terms of cytotoxicity toward mammalian cells.
3.3 | Morphological studies
SEM and AFM were used to generate high-resolution micros-
copy data on morphological alterations caused by the ocella-
tins under study on L. infantum promastigote forms. Both
techniques complement each other. AFM is a rather slow
high-resolution imaging technique that enables texture analy-
sis of the membranes, while SEM’s speed and wide ﬁeld
imaging allow an overview of the variety in morphology of
the cells. Typically for each sample, more than 20 cells were
scanned with SEM, while 4-6 cells were examined with the
AFM. This complementarity between SEM and AFM imaging
has been exploited by us to examine peptide-treated Leishma-
nia promastigotes previously.[26] Representative images from
both techniques are shown (Figures 3 and 4).
Examining the SEM images, considerable changes in the
membranes of the parasite body upon treatment with the pep-
tides was observed (Figure 3). Both ocellatin-PT1 and
ocellatin-PT8 has similar eﬀects. At the 16 mg/mL peptide
concentration (Figures 3B and 3C), the cells showed several
raised circular features, consistent with large vesicles in the
membrane. The images shown in Figure 3 are SE images.
Backscattered electron (BSE) images, acquired simultane-
ously are shown in the supporting information (Supporting
Information Figure S5). BSE images are less surface sensi-
tive, and show more information from deep within the sam-
ple. The BSE images revealed even more circular features
(presumably vesicles), as well as dark patches perhaps
reﬂecting areas of the membranes that had undergone mem-
brane thinning.[27] These features were largely absent from
control cells (see Figure 3A). After treatment at 64 mg/mL
(Figures 3D and 3E), the cells were further altered, the raised
“blister-like” swellings being replaced with what are appa-
rently deep holes in the cell body. In some cases, the appear-
ance of these holes gave the impression that the cell had
undergone lysis, while at 16 mg/mL, alterations were mostly
limited to vesicle appearance and collapse. In the BSE
images (Supporting Information Figure S5), dark patches
were sometimes observed along the membrane, as well as
more hole-like alteration as observed in the SE images. In
previous work it was observed that the shape of the cells
changed upon treatment with the AMP DRS-01, becoming
more rounded and signiﬁcantly shorter overall.[26] In this
work, we did not notice gross morphological changes of this
type in the images (see Figure 3 where the overall shape of
the cells does not change). Using lower magniﬁcation
images, we measure the length of the cell bodies, for the
cells treated with 16 mg/mL and found there were small but
non-signiﬁcant changes in cell length. Control cells meas-
ured 9.6± 2.2 (N=21), while Ocellatin PT-1-treated cells
measured 8.4± 1.3 mm (N=7), and Ocellatin PT-8-treated
cells measured 8.3± 2.2 mm (N=14).
Samples treated with 16 mg/mL peptide were also exam-
ined with AFM. These samples were treated in parallel with
the SEM samples, but neither metal-coated nor exposed to
vacuum. The lack of metal coating allows texture analysis
without interference from metal grains from the sputtering
procedure, and not exposing the cells to vacuum removed
the possibility of vacuum-induced morphological changes.
The images shown in Figure 4 largely show similar eﬀects to
those seen in the SEM samples. Circular features (sometimes
collapsed in the center) in the two treated samples indicated
the presence of blister-like features. Examination of the cell
surface images from the AFM results showed a change in
texture over the whole membrane in the treated sample com-
pared to the control. Measurement of roughness was
FIGURE 5 Surface roughness (Rq) measured by AFM on
the surface of promastigote forms of L. infantum cells. Raw
values were 2.78 nm (SD: 0.63,N: 25) for the control, 4.22 nm
(SD: 1.50,N: 22) for treatment with Ocellatin-PT1, and 5.08
(SD: 2.16,N: 18) for treatment with Ocellatin-PT8
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performed along the center of the cell membranes in treated
and untreated cells. All cells imaged were measured, and the
results averaged (Figure 5). The averages for both cells
treated with ocellatin-PT1 and -PT8 were higher than the
control cells. Further, the roughness of ocellatin-PT8-treated
cells was higher than that found after treatment with
ocellatin-PT1, although the diﬀerence was slight. In fact, the
standard deviation was quite large for all of these measure-
ments. This is not surprising, since the treated cells were
quite heterogeneous, and biological cells vary quite a lot in
roughness. Presumably due to the large variability in surface
texture, the results failed the Student’s t-test for statistical
signiﬁcance (p> .05), nevertheless suggest an overall change
in membrane texture upon treatment.
3.4 | Binding property of peptides to lipid membranes
The binding of the ocellatins PT-1 and PT-8 to lipid model
membranes was explored using SPR. DMPC, POPC:POPE
(75:25) and POPE:POPG (75:25) liposomes were used to
mimic mammalian, leishmania and bacteria membranes, cor-
respondingly. At the higher concentrations of peptide used,
the decrease of the SPR signal clearly showed that the lipid
bilayer was aﬀected by the peptide. In fact, lipid bilayers
were very unstable at high concentrations of the peptide,
making measurements unreliable. Therefore, we used sepa-
rate cycles of lipid deposition for each peptide concentration
tested. Supporting Information Figure S1 depicts an example
of an SPR experiment cycle, showing the deposition of the
FIGURE 6 Representative SPR sensorgrams obtained for Ocellatin-PT1 and Ocellatin-8 binding to mimetic model membranes.
(A) and (B) DMPC supported unilamellar bilayers. (C) and (D) POPE:POPG (75:25) supported unilamellar bilayers. (E) and (F)
POPC:POPE (75:25) supported unilamellar bilayers at four diﬀerent peptide concentrations ranging from 2–5 mM. Injections of
peptide occurred between t=0 and t=100 and the peptide was then allowed to dissociate for a further 600 seconds (between
t=100 and t=700 seconds) as buﬀer ﬂowed through the system
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lipid bilayer followed by the peptide injection and ﬁnalizing
with the lipid bilayer removal with CHAPS detergent. This
cycle was repeated for each peptide concentration used. The
sensorgrams obtained for the interactions of ocellatins-PT1
and PT-8 with the diﬀerent model membranes used are
depicted in Figure 6. The binding constants, calculated using
the kinetic two-state reaction model, are listed in Table 2.
For the mammalian cell mimetic liposomes (DMPC), Kass
was 2.95 3 103 for PT-1 and 2.18 3 104 for PT-8; for the
bacterial cells mimetic liposomes [POPE:POPG (75:25)],
Kass was 1.03 3 10
5 for PT-1 and 1.28 3 106 for PT-8 and
for the leishmania cells mimetic liposomes [POPC:POPE
(75:25)], Kass was 1.77 3 10
5 for PT1 and 1.94 3 105 for
PT8. The sensorgrams in Figure 6 can also give information
to make an analysis of the binding aﬃnity at the equilibrium
with a steady-state binding model. However, since we used
anti-bacterial peptides that, at high concentration, are able to
destroy the lipid membranes, we were forced to use a range
of small concentrations and thus we were unable to reach the
saturation concentration for these binding curves. Thus we
measured a linear dose–response relationship at the equilib-
rium and the results are shown in Figure 7. The slopes of the
linear plots are 48.6 for PT-1 and 97.7 for PT-8 with DMPC,
54.3 for PT-1 and 103.6 for PT-8 with POPE:POPG (75:25)
and 116.1 for PT-1 and 126.4 for PT-8 with POPC:POPE
(75:25). Overall, these results indicate a higher aﬃnity of
both PT-1 and PT-8 for bacteria and leishmania lipid mem-
branes rather than mammalian lipid membranes.
4 | DISCUSSION
4.1 | Biological assays and morphological studies
To the best of our knowledge, this work represents the ﬁrst
time that a wide range of related peptides have been tested
against antileishmania models.[28] The work showed that all
the analyzed ocellatin-PT peptides are active against Leishma-
nia promastigotes and some against amastigotes. Comparing
with previous results of antibacterial activity tests,[15a] we
observe slightly superior antiparasitic potency for the same
peptides. Conversely, the peptides have low toxicity for mac-
rophages conﬁrming previous studies with other mammalian
cells, a fact that may be related to diﬀerences in membrane
composition between the mammalian and parasitic cells.
Microscopy results showed considerable morphological
changes of L. infantum cells upon treatment with the
FIGURE 7 Dose–response relationship for the interaction of Ocellatin peptides with lipid ﬁlms (DMPC, POPC:POPE 75:25,
and POPE:POPG) from SPR data. The slopes of the lines ﬁtted to this relationship (a) were (A) Ocellatin-PT1 (a1 = 48.6,
a2= 116.1, a3 = 54.3; (B) Ocellatin-PT8 (a1= 97.7, a2 = 126.4, a3 = 103.6)
TABLE 2 Association (ka1 and ka2) and dissociation (kd1 and kd2) rate constants for interaction of the ocellatins with dif-
ferent membranes models, and aﬃnity constants (K) determined by numerical integration using the two-state reaction model
Peptide name Lipid type
ka1
(1/mol.dm23s) 3103
kd1
(1/s) 310
ka2
(1/s) 3103
kd2
(1/s)
1024
K
(mol.dm3)
103
Ocellatin-PT1 DMPC 0.212 2.36 3.51 15.5 2.95
POPE:POPG (75:25) 4219 3.12 5.89 8.60 103
POPC:POPE (75:25) 86.6 6.63 4.98 141 177
Ocellatin-PT8 DMPC 976 1.60 4.58 17.8 21.8
POPE:POPG (75:25) 31.9 2.31 9.41 11.4 1279
POPC:POPE (75:25) 17.5 1.77 4.20 43.5 194
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ocellatin-PT1 and ocellatin-PT8. However, diﬀerences in
morphological eﬀects between the two peptides tested were
not signiﬁcant. Comparing image results with those previ-
ously published where considerable roughening of the mem-
brane, shortening and rounding of the cells, as well as
apparent changes to ﬂagella was evidenced in promastigotes
cells after treatment with DRS-01,[26] we observed more
localized changes in promastigote cells after ocellatin-PT
peptides treatment. The membrane itself showed visible but
not signiﬁcant roughening, while large blister-like protru-
sions appeared at lower concentrations and large holes in the
membranes, some passing deep into the cell body, were
observed at higher concentrations. It seems likely these are
the result of the vesicalization/micellization of membrane lip-
ids also observed at lower concentrations, and clearly repre-
sent a complete undermining of the membrane structure. In
addition, at the lower concentration, the membranes showed
dark patches (lower contrast) in some regions. This could be
due to membrane thinning. Bearing in mind that this lower
concentration was below the IC50, while the higher concen-
tration was above it, it seems likely that formation of vesicles
and/or membrane thinning is a sub-lethal cell alteration
caused by these peptides, while the penetration of the mem-
branes illustrates eﬀects that occur at a lethal concentration.
It is clear from the literature,[27] that even among peptides
which act directly on lipid membranes, the actual mechanism
is a result of the combination of the speciﬁc peptide structure
and the lipid composition of the membrane under study.
Based on very diﬀerent microscopy results, using the same
parasite model, we conclude that the mechanisms of action
of these new ocellatin-PT peptides is diﬀerent to that of the
DRS-01 previously described, which has a very distinct
sequence compared to the ocellatins.[26]
4.2 | Structural studies, binding property of peptides to
the lipid membrane, and comparison with bioactivity
The structural study of the ocellatin-PT peptides lead to the
conclusion that these peptides most likely change their
sstructure when they contact microorganism membranes,
supporting the theory that the peptide interaction with the
microorganism’s membrane should be crucial for its activity,
as demonstrated by AFM with leishmania (in this work) and
with bacteria previously.[15a] However, there was no direct
relation between the changes seen in systems with model
membranes and the toxicity toward the modeled cell types.
This could mean either that the simple models used are not
adequate to fully probe secondary structures formed in con-
tact with cells, or that for these peptides, alpha-helical struc-
tures are not a prerequisite for the mode of action.
Ocellatin-PT peptide interactions with diﬀerent membrane
models was then further investigated in this work using SPR, a
technique that has been highlighted recently as one of the main
biochemical techniques used to study molecular interactions.[29]
The study of the binding of ocellatins PT-1 and PT-8 with diﬀer-
ent membrane models showed a higher aﬃnity of both peptides
for models for Gram-negative bacterial and leishmania mem-
branes when compared to mammalian membranes. This corre-
lates with previously described antibacterial tests and
cytotoxicity studies, suggesting that the selectivity is based on
membrane lipid composition.[15a] Anti-L. infantum and anti-E.
coli IC50 and MIC concentrations were 24 mmol.dm
23 and 300
mM respectively for ocellatin PT-1 and 15.5 mmol.dm23 and 60
mM respectively for ocellatin PT 8 while insigniﬁcant or null
hemolytic and cytotoxicity activity were observed at the deter-
mined IC50 and MICs.
In brief, ocellatin-PT peptides present a solvent-
dependent a-helix structure adoption that suggests a change
in conﬁrmation upon interaction with microorganisms. SPR
studies demonstrate that peptides have preferential aﬃnity
for parasite and bacterial membrane models compared to the
mammalian membrane model, this correlates with the in
vitro activity tests performed in this work and previously
with parasites, bacteria, human erythrocytes, murine ﬁbro-
blast cells and bone marrow-derived macrophages. High-
resolution microscopy techniques show peptide action
through pathogen-membrane morphology alteration that
could be due to membrane thinning and vesicle formation
with ﬁnal penetration provoking lysis. The mechanism of
action is likely a result of the combination of the peptide
structure and lipid composition of the membrane under
study. Based on the cationic nature of these peptides, and the
net positive charge of many bacterial membranes, the initial
step in interaction is likely to be dependent on electrostatic
interactions.[27] Similarly, electrostatic factors may explain
their low cytotoxicity toward mammalian cells.[30] These
results conﬁrm the potential of ocellatin peptides to be used
as therapeutic molecules due to high selectivity for microor-
ganism membranes against mammalian membranes. The cor-
relation of results between SPR, AFM and biological activity
allows the conclusion that the use of biophysical techniques
such as AFM and SPR enriches and complements the in
vitro study of activity of peptides against microorganisms.
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